Skip to content

Biochemical Predictors of Delirium in Cardiac Surgery

Biochemical Predictors of Delirium in Patients Undergoing Cardiac Surgery Under Cardiopulmonary Bypass

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03931499
Enrollment
100
Registered
2019-04-30
Start date
2019-06-10
Completion date
2021-01-31
Last updated
2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Brief summary

Delirium is a common neurologic complication after cardiac surgery occuring in 30-50% of patients. The occurence of this complication is associated with worse outcomes, including prolonged length of stay in the ICU and hospital, increased morbidity and mortality. Considering great clinical significance of this complication, the search for early predictors of postoperative delirium remains an urgent task. The purpose of this prospective observational study is to test the hypothesis that metabolomic changes before and after cardiac surgery could be served as early predictors of this complication.

Interventions

DIAGNOSTIC_TESTMetabolomic analysis

Blood will be collected in all patients blood before surgery and after surgery (postoperative day 1). Our study is based on a polar metabolomics profiling of plasma and/or serum using hybrid triple quadrupole mass spectrometer coupled with chromatographic system.

Sponsors

Novosibirsk State University
CollaboratorOTHER
Meshalkin Research Institute of Pathology of Circulation
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* surgery under cardiopulmonary bypass * Age \> 60 years * CABG surgery or valve surgery (repair/replacement)

Exclusion criteria

* urgent surgery * surgery on aorta * combined procedures (CABG+valves) * significant stenosis of carotid arteries * Parkinson's disease * liver cirrhosis * use of anticholinergic drugs, antidepressants, antiepileptic or chemotherapy drugs

Design outcomes

Primary

MeasureTime frameDescription
Postoperative delirium5 days after surgeryPostoperative delirium will be diagnosed with CAM-ICU (confusion assessment method - intensive care unit)

Countries

Russia

Contacts

Primary ContactVladimir Lomivorotov, MD, PhD
v.lomivorotov@gmail.com83833476058
Backup ContactGleb Moroz
glebmorozz@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026